α1-Adrenergic receptor signaling is localized to caveolae in neonatal rat cardiomyocytes

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 1, 2006, Pages 17-25

  Morris, James B ^a   Huynh, Huy ^a   Vasilevski, Oliver ^a   Woodcock, Elizabeth A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Inositol phospholipid; Light lipid rafts; Phospholipase C; Sarcolemma

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PHOSPHOLIPASE C; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CAVEOLIN 3; ISOENZYME; PHOSPHOLIPASE C BETA; PHOSPHOLIPID;

ANIMAL CELL; ARTICLE; CAVEOLA; CELL MEMBRANE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME SUBUNIT; HEART MUSCLE CELL; LIPID RAFT; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; SARCOLEMMA; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECT; DRUG POTENTIATION; METABOLISM;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CAVEOLAE; CAVEOLIN 3; CELLS, CULTURED; ISOENZYMES; MEMBRANE MICRODOMAINS; MYOCYTES, CARDIAC; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 4,5-DIPHOSPHATE; PHOSPHOLIPASE C; PHOSPHOLIPIDS; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; SIGNAL TRANSDUCTION;

EID: 33745336455     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.03.011     Document Type: Article

References (47)

1. 3: complex roles at the cell surface. Cell 100 (2000) 603-606
2. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19 (2000) 2537-2548
3. Howes A.L., Arthur J.F., Zhang T., Miyamoto S., Adams J.W., Dorn G.W., et al. Akt-mediated cardiomyocyte survival pathways are compromised by G αq-induced phosphoinositide 4,5-bisphosphate depletion. J. Biol. Chem. 278 (2003) 40343-40351
4. Kurz T., Kemken D., Mier K., Weber I., and Richardt G. Human cardiac phospholipase D activity is tightly controlled by phosphatidylinositol 4,5-bisphosphate. J. Mol. Cell. Cardiol. 36 (2004) 225-232
5. Park K.H., Piron J., Dahimene S., Merot J., Baro I., Escande D., et al. Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome. Circ. Res. 96 (2005) 730-739
6. 2. Science 273 (1996) 956-959
7. Nebl T., Oh S.W., and Luna E.J. Membrane cytoskeleton: PIP2 pulls the strings. Curr. Biol. 10 (2000) R351-R354
8. Carpenter C.L., and Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8 (1996) 153-158
9. Hinchliffe K.A., Ciruela A., Morris J.A., Divecha N., and Irvine R.F. The type II PIPkins (Ptdlns5P 4-kinases): enzymes in search of a function?. Biochem. Soc. Trans. 27 (1999) 657-661
10. Kuraja I.J., Tanner J.K., and Woodcock E.A. Endothelin stimulates phosphatidylinositol turnover in rat right and left atria. Eur. J. Pharmacol. 189 (1990) 299-306
11. Woodcock E.A., and Lambert K.A. The inositol phosphate response to thrombin in rat right atria differs from the response to noradrenaline. Eur. J. Pharmacol., Mol. Pharmacol. Sect. 291 (1995) 213-216
12. 1 in rat neonatal cardiomyocytes. J. Biol. Chem. 276 (2001) 37341-37346
13. Du X.-J., Anderson K., Jacobsen A., Woodcock E., and Dart A. Suppression of ventricular arrhythmias during ischaemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Circulation 91 (1995) 2712-2716
14. 3)-receptor type 2-deficient mice. Circ. Res. 96 (2005) 1274-1281
15. + current in atrial myocytes. J. Biol. Chem. 276 (2001) 5650-5658
16. 1b-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J. Clin. Invest. 111 (2003) 1783-1791
17. Woodcock E.A., Wang B.H., Arthur J.F., Lennard A., Matkovich S.J., Du X.-J., et al. Inositol polyphosphate 1′ phosphatase is a novel anti-hypertrophic factor. J. Biol. Chem. (2002) 22734-22742
18. Morris J.B., Pham T.M., Kenney B., Sheppard K.E., and Woodcock E.A. UTP transactivates epidermal growth factor receptors and promotes cardiomyocyte hypertrophy despite inhibiting transcription of the hypertrophic marker gene, atrial natriuretic peptide. J. Biol. Chem. 279 (2004) 8740-8746
19. Sah V.P., Hoshijima M., Chien K.R., and Brown J.H. Rho is required for G αq and αi-adrenergic receptor signaling in cardiomyocytes-Dissociation of Ras and Rho pathways. J. Biol. Chem. 271 (1996) 31185-31190
20. Rybin V.O., Xu X.H., and Steinberg S.F. Activated protein kinase C isoforms target to cardiomyocyte caveolae-Stimulation of local protein phosphorylation. Circ. Res. 84 (1999) 980-988
21. Woodcock E., Suss M., and Anderson K. Inositol phosphate release and metabolism in rat left atria. Circ. Res. 76 (1995) 252-260
22. Cannon-Carlson S., and Tang J. Modification of the Laemmli sodium dodecyl sulfate-polyacrylamide gel electrophoresis procedure to eliminate artifacts on reducing and nonreducing gels. Anal. Biochem. 246 (1997) 146-148
23. Divecha N., Banfic H., and Irvine R.F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-1) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase-c to the nucleus. EMBO J. 10 (1991) 3207-3214
24. 1 generated by alternative splicing. J. Biol. Chem. 269 (1994) 8240-8245
25. Banno Y., Asano T., and Nozawa Y. Proteolytic modification of membrane-associated phospholipase C-β by μ-calpain enhances its activation βγ G-protein bg subunits in human platelets. FEBS Lett. 340 (1994) 185-188
26. Chen X., and Resh M.D. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J. Biol. Chem. 277 (2002) 49631-49637
27. + currents in rat ventricular myocytes. Circ. Res. 91 (2002) 232-239
28. 2 hydrolysis. Nat. Cell Biol. 4 (2002) 329-336
29. 2 by cardioactive hormones and other physiologically relevant interventions. Am. J. Physiol. 283 (2002) C223-C234
30. Rybin V.O., Xu X., Lisanti M.P., and Steinberg S.F. Differential targeting of β-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J. Biol. Chem. 275 (2000) 41447-41457
31. Hua H., Munk S., and Whiteside C.I. Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am. J. Physiol. 284 (2003) F303-F312
32. Huo H.R., Guo X.M., Hong S.Y., Jiang M.R., Liu X.Y., and Liao K. Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-l1 preadipocyte differentiation induction. J. Biol. Chem. 278 (2003) 11561-11569
33. Pike L.J., and Casey L. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41 (2002) 10315-10322
34. 3 pathways in neurons. Neuron 34 (2002) 209-220
35. Cottingham K. Do you believe in lipid rafts?. Anal. Chem. 76 (2004) 403A-406A
36. Pike L.J., and Casey L. Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 271 (1996) 26453-26456
37. Waugh M.G., Minogue S., Anderson J.S., dosSantos M., and Hsuan J.J. Signalling and non-caveolar rafts. Biochem. Soc. Trans. 29 (2001) 509-512
38. 2 signaling in lipid domains: a critical re-evaluation. EMBO J. 24 (2005) 1664-1673
39. Brough D., Bhatti F., and Irvine R.F. Mobility of proteins associated with the plasma membrane by interaction with inositol lipids. J. Cell Sci. 118 (2005) 3019-3025
40. Pizzo P., and Viola A. Lymphocyte lipid rafts: structure and function. Curr. Opin. Immunol. 15 (2003) 255-260
41. Cho H., Kim Y.A., Yoon J.Y., Lee D., Kim J.H., Lee S.H., et al. Low mobility of phosphatidylinositol 4,5-bisphosphate underlies receptor specificity of Gq-mediated ion channel regulation in atrial myocytes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 15241-15246
42. 1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc. Res. 51 (2001) 709-716
43. Lanzafame A.A., Turnbull L., Amiramahdi F., Arthur J.F., Huynh H., and Woodcock E.A. Inositol phospholipids localized to caveolae in rat heart are regulated by a1-adrenergic receptors and by ischemia/reperfusion. Am J Physiol 290 (2006) 2059-2065
44. 2-adrenergic receptor signaling in ventricular myocytes: the role of Gi proteins and caveolae microdomains. Mol. Pharmacol. 63 (2003) 1338-1348
45. Rybin V.O., Grabham P.W., Elouardighi H., and Steinberg S.F. Caveolae-associated proteins in cardiomyocytes: caveolin-2 expression and interactions with caveolin-3. Am. J. Physiol. 285 (2003) H325-H332
46. Head B.P., Patel H.H., Roth D.M., Lai N.C., Niesman I.R., Farquhar M.G., et al. G-protein coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J. Biol. Chem. 280 (2005) 31036-31044
47. Wong W., and Schlichter L.C. Differential recruitment of Kv1.4 and Kv4.2 to lipid rafts by PSD-95. J. Biol. Chem. 279 (2004) 444-452